Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 761

1.

Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.

Sevigny JJ, Albert SM, McDermott MP, McArthur JC, Sacktor N, Conant K, Schifitto G, Selnes OA, Stern Y, McClernon DR, Palumbo D, Kieburtz K, Riggs G, Cohen B, Epstein LG, Marder K.

Neurology. 2004 Dec 14;63(11):2084-90.

PMID:
15596754
2.

An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection.

Sevigny JJ, Albert SM, McDermott MP, Schifitto G, McArthur JC, Sacktor N, Conant K, Selnes OA, Stern Y, McClernon DR, Palumbo D, Kieburtz K, Riggs G, Cohen B, Marder K, Epstein LG.

Arch Neurol. 2007 Jan;64(1):97-102.

PMID:
17210815
3.

Markers of immune activation and viral load in HIV-associated sensory neuropathy.

Schifitto G, McDermott MP, McArthur JC, Marder K, Sacktor N, McClernon DR, Conant K, Cohen B, Epstein LG, Kieburtz K; NEAD Consortium.

Neurology. 2005 Mar 8;64(5):842-8.

PMID:
15753420
4.

Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.

McArthur JC, McDermott MP, McClernon D, St Hillaire C, Conant K, Marder K, Schifitto G, Selnes OA, Sacktor N, Stern Y, Albert SM, Kieburtz K, deMarcaida JA, Cohen B, Epstein LG.

Arch Neurol. 2004 Nov;61(11):1687-96. Erratum in: Arch Neurol. 2005 Jul;62(7):1110.

PMID:
15534180
5.

Antiretroviral treatment alters relationship between MCP-1 and neurometabolites in HIV patients.

Chang L, Ernst T, St Hillaire C, Conant K.

Antivir Ther. 2004 Jun;9(3):431-40.

PMID:
15259906
6.

Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.

McArthur JC, McClernon DR, Cronin MF, Nance-Sproson TE, Saah AJ, St Clair M, Lanier ER.

Ann Neurol. 1997 Nov;42(5):689-98.

PMID:
9392567
7.

The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.

Jevtović Dj, Vanovac V, Veselinović M, Salemović D, Ranin J, Stefanova E.

Biomed Pharmacother. 2009 Sep;63(8):561-5. doi: 10.1016/j.biopha.2008.09.015. Epub 2008 Nov 5.

PMID:
19026516
8.

Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.

Sánchez-Ramón S, Bellón JM, Resino S, Cantó-Nogués C, Gurbindo D, Ramos JT, Muñoz-Fernández MA.

Pediatrics. 2003 Feb;111(2):E168-75.

PMID:
12563091
9.

Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.

Wood E, Hogg RS, Yip B, Moore D, Harrigan PR, Montaner JS.

AIDS. 2006 May 12;20(8):1117-23.

PMID:
16691062
11.

Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy.

Childs EA, Lyles RH, Selnes OA, Chen B, Miller EN, Cohen BA, Becker JT, Mellors J, McArthur JC.

Neurology. 1999 Feb;52(3):607-13.

PMID:
10025796
12.

Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression. Leukine/HIV Study Group.

Angel JB, High K, Rhame F, Brand D, Whitmore JB, Agosti JM, Gilbert MJ, Deresinski S.

AIDS. 2000 Mar 10;14(4):387-95.

PMID:
10770541
13.

CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.

Kaufmann GR, Perrin L, Pantaleo G, Opravil M, Furrer H, Telenti A, Hirschel B, Ledergerber B, Vernazza P, Bernasconi E, Rickenbach M, Egger M, Battegay M; Swiss HIV Cohort Study Group.

Arch Intern Med. 2003 Oct 13;163(18):2187-95.

PMID:
14557216
14.

HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people.

Vitiello B, Goodkin K, Ashtana D, Shapshak P, Atkinson JH, Heseltine PN, Eaton E, Heaton R, Lyman WD.

AIDS. 2007 Jul 11;21(11):1415-22.

PMID:
17589187
15.

Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals.

De Luca A, Ciancio BC, Larussa D, Murri R, Cingolani A, Rizzo MG, Giancola ML, Ammassari A, Ortona L.

Neurology. 2002 Aug 13;59(3):342-7.

PMID:
12177366
16.

CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.

Valle M, Price RW, Nilsson A, Heyes M, Verotta D.

Brain. 2004 May;127(Pt 5):1047-60. Epub 2004 Mar 10.

PMID:
15013955
17.

Dynamics of monocyte chemoattractant protein type one (MCP-1) and HIV viral load in human cerebrospinal fluid and plasma.

Monteiro de Almeida S, Letendre S, Zimmerman J, Lazzaretto D, McCutchan A, Ellis R.

J Neuroimmunol. 2005 Dec;169(1-2):144-52. Epub 2005 Sep 22.

PMID:
16182380
18.

Platelet decline: an avenue for investigation into the pathogenesis of human immunodeficiency virus -associated dementia.

Wachtman LM, Skolasky RL, Tarwater PM, Esposito D, Schifitto G, Marder K, McDermott MP, Cohen BA, Nath A, Sacktor N, Epstein LG, Mankowski JL, McArthur JC.

Arch Neurol. 2007 Sep;64(9):1264-72.

PMID:
17846264
19.

Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.

Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, De Luca A, Puoti M, Petrelli E, Carnevale G, Rizzardini G, Grossi PA, Viganò P, Moioli MC, Carletti F, Solmone M, Ippolito G, Monforte AD; HepaI.Co.N.A. Study Group; Italian Cohort Naive for Antiretrovirals Study Group.

Clin Infect Dis. 2005 Jun 15;40(12):e101-9. Epub 2005 May 5.

PMID:
15909251
20.

Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion.

Marcotte TD, Deutsch R, McCutchan JA, Moore DJ, Letendre S, Ellis RJ, Wallace MR, Heaton RK, Grant I; San Diego HIV Neurobehavioral Research Center (HNRC) Group.

Arch Neurol. 2003 Oct;60(10):1406-12.

PMID:
14568811

Supplemental Content

Support Center